ZA200110470B - Aspartate deribative of amlodipine. - Google Patents
Aspartate deribative of amlodipine.Info
- Publication number
- ZA200110470B ZA200110470B ZA200110470A ZA200110470A ZA200110470B ZA 200110470 B ZA200110470 B ZA 200110470B ZA 200110470 A ZA200110470 A ZA 200110470A ZA 200110470 A ZA200110470 A ZA 200110470A ZA 200110470 B ZA200110470 B ZA 200110470B
- Authority
- ZA
- South Africa
- Prior art keywords
- deribative
- amlodipine
- aspartate
- aspartate deribative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/90—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having more than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25860200P | 2000-12-29 | 2000-12-29 | |
US80934901A | 2001-03-16 | 2001-03-16 | |
BE2001/0712A BE1014455A6 (nl) | 2000-12-29 | 2001-11-05 | Aspartaatderivaat van amlodipine. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200110470B true ZA200110470B (en) | 2002-07-11 |
Family
ID=29740328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200110470A ZA200110470B (en) | 2000-12-29 | 2001-12-20 | Aspartate deribative of amlodipine. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6479525B2 (fr) |
EP (1) | EP1309558A1 (fr) |
BE (1) | BE1014455A6 (fr) |
BR (1) | BR0116553A (fr) |
CA (2) | CA2433191A1 (fr) |
CR (1) | CR7011A (fr) |
DE (1) | DE20116170U1 (fr) |
GB (1) | GB2372036B (fr) |
GR (1) | GR1004124B (fr) |
HU (1) | HUP0105456A3 (fr) |
IE (1) | IES20011105A2 (fr) |
MX (1) | MXPA03005886A (fr) |
WO (1) | WO2002053540A1 (fr) |
ZA (1) | ZA200110470B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2287110T3 (es) * | 2000-04-11 | 2007-12-16 | Sankyo Company, Limited | Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina. |
MXPA03005882A (es) * | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
EP1309554A1 (fr) * | 2000-12-29 | 2003-05-14 | Synthon Licensing, Ltd. | Derive d'amide d'amlodipine |
US6653481B2 (en) * | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
BR0116557A (pt) * | 2000-12-29 | 2003-10-28 | Pfizer Ltd | Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina |
KR100467669B1 (ko) * | 2002-08-21 | 2005-01-24 | 씨제이 주식회사 | 암로디핀의 유기산염 |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
ES2886067T3 (es) | 2016-10-07 | 2021-12-16 | Silvergate Pharmaceuticals Inc | Formulaciones de amlodipina |
EP3773574A4 (fr) | 2018-04-11 | 2022-03-02 | Silvergate Pharmaceuticals, Inc. | Formulations d'amlodipine |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
US4983740A (en) | 1986-08-04 | 1991-01-08 | Adir Et Compagnie | Process for 1,4-dihydropyridine compounds |
GB8710493D0 (en) | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
US5155120A (en) | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
WO1993006082A1 (fr) | 1991-09-13 | 1993-04-01 | Merck & Co., Inc. | Procede de preparation de 1,4-dihyropyridines-4-substitues |
US5389654A (en) | 1992-11-26 | 1995-02-14 | Lek, Tovarna, Farmacevtskih In Kemicnih . . . | 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate |
HU221810B1 (hu) | 1997-08-12 | 2003-01-28 | EGIS Gyógyszergyár Rt. | Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei |
ZA9810320B (en) | 1997-11-14 | 2000-05-11 | Gea Farmaceutisk Fabrik As | Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose. |
PL189666B1 (pl) | 1998-04-09 | 2005-09-30 | Adamed Sp Z Oo | Sposób otrzymywania benzenosulfonianu amlodypiny |
GB9812413D0 (en) | 1998-06-10 | 1998-08-05 | Glaxo Group Ltd | Compound and its use |
ES2151850B1 (es) | 1998-10-26 | 2001-08-16 | Esteve Quimica Sa | Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente. |
GB9827387D0 (en) | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel process |
GB9827431D0 (en) | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
GB2371862B (en) | 2000-12-29 | 2004-07-14 | Bioorg Bv | Reference standards for determining the purity or stability of amlodipine maleate and processes therefor |
AT5874U1 (de) * | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
BR0116557A (pt) * | 2000-12-29 | 2003-10-28 | Pfizer Ltd | Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina |
GB0114709D0 (en) | 2001-06-15 | 2001-08-08 | Pfizer Ltd | Stabilised formulations of amlodipine maleate |
-
2001
- 2001-08-15 BR BR0116553-4A patent/BR0116553A/pt not_active Application Discontinuation
- 2001-08-15 GB GB0131064A patent/GB2372036B/en not_active Expired - Fee Related
- 2001-08-15 MX MXPA03005886A patent/MXPA03005886A/es active IP Right Grant
- 2001-08-15 CA CA002433191A patent/CA2433191A1/fr not_active Abandoned
- 2001-08-15 WO PCT/NL2001/000603 patent/WO2002053540A1/fr active Application Filing
- 2001-08-15 EP EP01974985A patent/EP1309558A1/fr not_active Withdrawn
- 2001-08-27 US US09/938,817 patent/US6479525B2/en not_active Expired - Fee Related
- 2001-10-02 DE DE20116170U patent/DE20116170U1/de not_active Ceased
- 2001-11-05 BE BE2001/0712A patent/BE1014455A6/nl not_active IP Right Cessation
- 2001-12-20 ZA ZA200110470A patent/ZA200110470B/xx unknown
- 2001-12-21 IE IE20011105A patent/IES20011105A2/en not_active IP Right Cessation
- 2001-12-27 HU HU0105456A patent/HUP0105456A3/hu unknown
- 2001-12-28 CA CA002366391A patent/CA2366391C/fr not_active Expired - Fee Related
- 2001-12-28 GR GR20010100602A patent/GR1004124B/el unknown
-
2003
- 2003-06-26 CR CR7011A patent/CR7011A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE20116170U1 (de) | 2002-04-04 |
GR20010100602A (el) | 2002-10-09 |
BR0116553A (pt) | 2004-02-03 |
GB2372036B (en) | 2004-05-19 |
WO2002053540A1 (fr) | 2002-07-11 |
HUP0105456A2 (en) | 2002-10-28 |
CA2433191A1 (fr) | 2002-07-11 |
GR1004124B (el) | 2003-01-24 |
CA2366391C (fr) | 2005-10-18 |
MXPA03005886A (es) | 2005-04-19 |
CA2366391A1 (fr) | 2002-06-29 |
GB2372036A (en) | 2002-08-14 |
BE1014455A6 (nl) | 2003-10-07 |
US6479525B2 (en) | 2002-11-12 |
CR7011A (es) | 2004-03-10 |
GB0131064D0 (en) | 2002-02-13 |
HU0105456D0 (en) | 2002-02-28 |
EP1309558A1 (fr) | 2003-05-14 |
IES20011105A2 (en) | 2002-12-30 |
HUP0105456A3 (en) | 2004-01-28 |
US20020128296A1 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3391801A (en) | Pyridinylimidazoles | |
AU8274301A (en) | Electro-powder | |
DE50104081D1 (en) | Hydrolager | |
GB0126795D0 (en) | Reorder-assistance functionality levels | |
AU6803901A (en) | Bis-arylsulfones | |
TWI315197B (en) | Combinations | |
DE60142731D1 (en) | Ation | |
DE50102859D1 (en) | Hochfliessfähige propylenblockcopolymerisate | |
AU9385201A (en) | Sulfonylguanidine | |
DE50107703D1 (en) | Creatininsensor-kalibration | |
ZA200110470B (en) | Aspartate deribative of amlodipine. | |
DE50008626D1 (en) | Substituierte aminomethyl-phenyl-cyclohexanderivate | |
AU6619001A (en) | Liquid-pourers | |
DE50008447D1 (en) | Aminomethyl-phenyl-cyclohexanonderivate | |
AU4686401A (en) | Hypotensors | |
AU9187601A (en) | Triazolo-epothilones | |
DE50006446D1 (en) | Otoplastik | |
DE50100877D1 (en) | Thermoverformbares verbundmaterial | |
GB0001369D0 (en) | Home safe | |
AU143621S (en) | Time piece | |
GB0028849D0 (en) | Improved keysheath | |
AU4831301A (en) | Gm-negative ehv-mutants | |
AU8756801A (en) | Thienopyrrolidinones | |
DE50003404D1 (en) | Multi-master-bus-system | |
DE50013705D1 (en) | Otoplastik |